Harlem Biospace Presents: VC Funding for Life Sciences in NYC
December 07, 2017
Steve Goodman, Jason Park, Niyoshi Patel
Davis Auditorium of Columbia University
530 W 120th Street
New York, NY
Join us for a panel discussion on VC funding for life sciences in NYC! We have panelists from a life science angel investor group, a venture capital firm, and a pharmaceutical company.
Stephen M. Goodman is a co-founder of Mid Atlantic Bio Angels (www.bioangels.net), a life science angel investor group, and 1st Pitch Life Science (www.1stpitchlifescience.com), a public forum for pitches from pre-investment stage life science companies. He has mentored numerous start-ups through the Columbia-Coulter Translational Research Partnership, the Bench to-Bedside Initiative of Weill-Cornell, Memorial Sloan Kettering and Rockefeller University and the NYC E-Lab for Life Science Entrepreneurship. Mr. Goodman is also a partner and co-head of the Life Sciences Group at Pryor Cashman LLP in New York City. His clients include drug development and diagnostic companies, medical device companies, clinical trial management companies and companies in other technology businesses. He has served as the chair of the Biotechnology Law Committee of the American Bar Association’s Science and Technology Law Section and sits on the editorial board of The SciTech Lawyer, published by that section.
Jason Park joined Flagship Pioneering in 2015 and focuses on life science investments. He is based in New York City, where he is helping lead the firm’s activities in the development of the city’s life sciences industry. Prior to joining Flagship, Jason was with the Boston Consulting Group where he was a core member of the Health Care, Strategy, and Technology teams. Jason led projects across a broad variety of topics, including early stage R&D, portfolio investment strategy, biopharmaceutical manufacturing, strategic and commercial due diligence, and global health. His time at BCG included wide geographic exposure, including years abroad as a member of the Mumbai and Paris offices. Earlier in his career, Jason was a director at an early stage biotech start-up focused on targeted drug delivery as well as the co-founder of an internet advertising firm. Jason holds a Ph.D., an M.S. and a B.S. in biomedical engineering from Yale University, where he continues to serve as an external venture creation mentor. His research focused on the use of nanotechnology for immunomodulatory purposes and he is the author of several book chapters and numerous peer-reviewed publications.
Niyoshi is currently on the business development team at Purdue Pharma, where she focuses on executing various acquisitions and licensing agreements for the company in multiple therapeutic areas. Previously she worked in private equity at Athyrium Capital and Great Point Partners, where she worked on investments across various healthcare sectors, including therapeutics, medical devices, and services. Niyoshi received a B.A. in Biology and a B.S. in Economics with a concentration in Finance from the University of Pennsylvania.
Submit questions for the panelists here.
Free event, great networking opportunity with snacks and drinks